Retatrutide targets three hormones instead of one, helping trial participants achieve unprecedented levels of weight-loss ...

Eli Lilly, a U.S. pharmaceutical company, announced that its next-generation obesity treatment under development achieved ...

Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they ...

As the number of users of obesity treatments increases, the competition for leadership over next-generation products is ...

Tirzepatide leads near-term, Retatrutide targets Class III, Foundayo expands maintenance—see 2030 sales & $1,300 PT.

An ex-Special Forces colonel tipped as a future prime minister has claimed almost £36,000 in taxpayer money for ...

The real goal is to lose excess fat while protecting muscle, strength, joint health, posture, balance, and metabolism.

Eli Lilly and Company today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound ...

THEY are arguably the biggest medical breakthrough of recent times, helping Brits to shed the pounds with barely any effort at all. So-called ‘fat jabs’ have had a surge of popularity and now, one ...

Manufactured by Eli Lilly and Company, both Mounjaro and Zepbound contain the active ingredient tirzepatide. Tirzepatide is similar to semaglutide, which is used in medications like Ozempic, Rybelsus, ...

One of Stoke-on-Trent's best-loved hotels is ready to reopen - after being cleared of asylum seekers. The North Stafford Hotel - opposite Stoke Station - stopped taking reservations and weddings were ...

The starting dosage of Mounjaro is 2.5 milligrams (mg) once per week for 4 weeks, followed by a maintenance dosage of 5 mg once per week. If needed, your doctor may increase your dose in increments of ...